Company Profiles

driven by the PitchBook Platform

Courtagen Life Sciences

Description

Developer of protein biomarker analysis systems for research, pre-clinical and clinical diagnostic applications in the life sciences industry. The company's products include Biomarker Workstation, a multiplex immunoassay system for disease biomarker testing applications and PATH, which are protein microarray ultra-thin nitrocellulose slides for building quantitative, multiplexed and single capture immunoassays.

2003

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$20M

Latest Deal Amount

$41.3M

Total Amount Raised

Description

Developer of protein biomarker analysis systems for research, pre-clinical and clinical diagnostic applications in the life sciences industry. The company's products include Biomarker Workstation, a multiplex immunoassay system for disease biomarker testing applications and PATH, which are protein microarray ultra-thin nitrocellulose slides for building quantitative, multiplexed and single capture immunoassays.

Website:

www.courtagen.com

Formerly Known As

Decision Biomarkers, Avantra Biosciences

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

12 Gill Street Suite 3700 Woburn, MA 01801United States +1 (877) 395-7608
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Courtagen Life Sciences's full profile, request a free trial.

Courtagen Life Sciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Courtagen Life Sciences Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bunker Hill CapitalPE/BuyoutMinority000 0000000 0000
Courtagen CapitalVenture CapitalMinority000 0000000 0000
Erik MooreAngel (individual)Minority000 0000000 0000
First Analysis GroupGrowth/ExpansionMinority000 0000000 0000
Fort Point AngelsAngel GroupMinority000 0000000 0000
Bunker Hill Capital PE/Buyout
Courtagen Capital Venture Capital
Erik Moore Angel (individual)
First Analysis Group Growth/Expansion
Fort Point Angels Angel Group

Courtagen Life Sciences Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Jeff ForwardChief Financial Officer
Kevin McKernanChief Scientific Officer
Mann ShoffnerDirector, Corporate Development
Christopher ManthousDirector, Sales
Christine Stanley Ph.DChief Laboratory Director, Clinical Genomics
Jeff Forward Chief Financial Officer
Kevin McKernan Chief Scientific Officer
Mann Shoffner Director, Corporate Development
Christopher Manthous Director, Sales
Christine Stanley Ph.D Chief Laboratory Director, Clinical Genomics

Courtagen Life Sciences Board Members (11)

NameRepresentingRoleSinceContact
Info
Brendan McKernanCourtagen Life SciencesPresident, Co-Founder & Board Member000 0000
Brian McKernanCourtagen Life SciencesChief Executive Officer, Board Member & Co-Founder000 0000
Charles FarkasSelfBoard Member000 0000
Emery OlcottSelfBoard Member000 0000
Joseph Keegan Ph.DSelfBoard Member000 0000
Brendan McKernan President, Co-Founder & Board Member Courtagen Life Sciences
Brian McKernan Chief Executive Officer, Board Member & Co-Founder Courtagen Life Sciences
Charles Farkas Board Member Self
Emery Olcott Board Member Self
Joseph Keegan Ph.D Board Member Self
Request full access to PitchBook